Xenon Pharmaceuticals (XENE) Tops Q4 EPS by 1c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q4 EPS of ($0.84), $0.01 better than the analyst estimate of ($0.85).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• BitGo to reduce workforce by nearly 15%
• SanDisk stock target lifted by Citi on continued demand strength
• HIVE Digital raises $115M through exchangeable senior notes offering